Bio-Techne Corporation

Bio-Techne Corporation is a global life sciences company headquartered in Minneapolis, Minnesota, USA. The company's mission is to empower scientists and clinicians to achieve better answers and advance science and medicine, ultimately improving the quality of life. It specializes in the development, manufacture, and sale of life science reagents, instruments, and services for the research, diagnostic, and bioprocessing markets worldwide.

Bio-Techne offers an extensive portfolio of over 500,000 products, including recombinant proteins, antibodies, immunoassays, nucleic acid probes and kits, single-cell analysis solutions, and automated protein analysis systems. The company operates primarily through two segments: Protein Sciences and Diagnostics and Spatial Biology. Its key brands, such as R&D Systems, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics (ACD), Asuragen, and Lunaphore, serve academic researchers, biopharmaceutical and biotechnology companies, and clinical diagnostic laboratories.

Kim Kelderman assumed the role of President and Chief Executive Officer of Bio-Techne Corporation on February 1, 2024, succeeding Chuck Kummeth. The company has recently focused on expanding its spatial biology solutions, including the COMET™ suite and SPYRE Focus Panels. Bio-Techne reported over $1.2 billion in net sales for fiscal year 2025 and maintains a strong market position, recognized for its leadership in proteins, immunoassays, and clinical diagnostic controls within the life sciences sector.